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ABSTRACT
A sample work-up and enrichment technique involving the use of supported liquid membrane (SLM) and detection by high
performance liquid chromatography coupled to a mass spectrometer operating under positive ion electrospray mode
(LC-PI-ESI-MS) has been developed for the determination of six anabolic androgenic compounds in different biomatrices;
mainly urine, kidney, liver and milk. Anabolic androgenic compounds analysed included 17-trenbolone, 17-trenbolone,
19-nortestosterone, testosterone, 4-androstene-3,17-dione and testosterone benzoate. Several factors affecting the extraction
efficiency during SLM enrichment, such as donor pH were studied. The detection limits (DL) were 0.08 µg L–1 for
4-androstene-3,17-dione, 0.7 ng L–1 19-testosterone, 1.1 ng L–1 for testosterone, 0.1 ng L–1 for 17-trenbolone, 1.6 ng L–1 for
17-trenbolone and 0.03 µg L–1 for testosterone benzoate. Modification at C17 in the structures of 4-androstene-3,17-dione and
testosterone benzoate affected their recoveries with SLM and explained their observed high detection limits.
KEYWORDS
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1. Introduction
The use of supported liquid membrane (SLM)-assisted extraction
as a sample preparation technique has proved to be an attractive
alternative to many others due to its high selectivity and enrich-
ment power.1 In the recent past many publications have
reported the effectiveness and the advantages of SLM in the
extraction and selective enrichment of a number of ionizing
organic pollutants in both natural and biological medium.
Audunson first reported the use of supported liquid membranes
in the determination of amines2,3 and later the technique found
applications in the enrichment of metals in natural waters.4–6 The
same technique has been used in the monitoring of benzi-
midazole anthelmintics, sulfonamides and macrolides in
various biomatrices.7–9 SLM has also been used successfully in
the enrichment of herbicides in natural water samples.10–12 In
this work supported liquid membranes were used for the
enrichment of anabolic androgenic compounds which are used
in animal husbandry as growth promoters.13–17 The same
compounds are frequently abused in the sports industry
because they have been shown to elevate the performance of
athletes. Consequently, they have been banned in sports since
the Olympic games in Montreal in 1976.14,15,18–20 Their use in
veterinary industry may lead to residues in meat and meat
products, which could be harmful to the consumers. Some of the
anabolic compounds are known carcinogens and prolonged
ingestion of large doses could disturb the endocrine balance and
hence lead to a large number of side-effects.15 Breast enlarge-
ment21 and precocious puberty22 are examples of side-effects
associated with these compounds. Concerns of consumer
exposure to some of these residues have led many National and
International health institutions, particularly in the European
Union (EU) to ban their use as growth promoters.17
The residues of anabolic compounds in biological matrices
such as animal tissue (meat), faeces, urine, animal feed, food
products (milk, etc.) and plasma have been monitored by a wide
variety of techniques. These include immunoassay techniques
such as radioimmunoassay (RIA), enzyme immunoassay (EIA)
and enzyme linked immunosorbent assay (ELISA).23–25 Although
these methods are sensitive and useful for screening purposes,
they are limited to single-compound analysis and can some-
times lead to false positive results.26 In addition to immunoassay,
other methods such as thin layer chromatography (TLC) and
high performance liquid chromatography (HPLC) coupled with
a variety of detection systems have been utilized for confirma-
tory purposes.27–33 Trenbolone and diethylstilbestrol, for exam-
ple, were analysed using HPLC with UV detection.34–35
Trenbolone and testosterone have also been determined by
HPLC with fluorescence detection.36
Gas chromatography (GC) and gas chromatography-mass
spectrometry (GC-MS) are the most commonly used techniques
for the analysis of anabolic compounds.37–44 However, both GC
and GC-MS require derivatization prior to analysis due to
the lack of volatility and the thermal instability of anabolic
compounds.45 Examples of GC-MS application include the
monitoring of some of the anabolic hormones in muscles via
pentafluoropropionyl derivatization and quantification of
anabolic drugs in meat after conversion to trimethylsilyl esters
by GC-EI-MS.46,47
Liquid chromatography on the other hand, is a more attractive
method of monitoring anabolic compounds since derivatization
is not a requirement.45 However, the limitation of HPLC in the
monitoring of anabolic compounds has been the lack of sensitiv-
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ity and selectivity of traditional LC de-
tectors. The advent of LC-MS interfaces
have, however, minimized the
limitation of this approach. LC-MS
methods can now offer sensitivity and
selectivity similar to that of GC-MS
without the need for prior derivati-
zation. The capabilities of MS as a detec-
tor exceed all the conventional GC or
LC detectors. The use of a MS detector
in SIM mode (selected ion monitoring)
not only adds to the selectivity but also
enhances the sensitivity of the method.
A sample preparation technique that
has been widely reported for the
clean-up and/or enrichment of anabolic
androgenic steroid hormones involve
the use of solid phase extraction (SPE).
Most of SPE cartridges can, however,
only be used once and the constant re-
placement of cartridges increases the
cost of analysis. We report the use of
supported liquid membranes in the
enrichment of androgenic compounds
in various biological matrices. Among
the advantages of SLM are low organic
solvent to feed volume ratio, low con-
centrations of extractants, high feed to
strip ratio, low capital and operating
costs, low energy requirements, a high
degree of cleanup and the possibility to
achieve high preconcentration fac-
tors47–52 The theory of SLM extraction is
well documented by Jönsson and
Mathiasson.50–52
2. Experimental
2.1. Materials and Reagents
The anabolic androgenic compounds used in this study
(17-trenbolone, 17-trenbolone, 4-androstene-3,17-dione,
19-nortesterone, testosterone benzoate and testosterone) were
all purchased from Sigma (St Louis, USA). Table 1 shows the
structures, molecular weights and CAS numbers of the investi-
gated compounds. HPLC grade methanol and diethyl ether
were obtained from BDH Laboratory Supplies (Poole, UK). All
organic solvents used in this work were filtered through a
0.45 µm organic membrane filter, type HVLP, Millipore (Dublin,
Ireland). Ultra high purity water (UHP) was processed through a
Millipore Quantum Ultrapure Ionex Gradient A10 purification
system (Millipore, Molsheim-France). Aqueous solvents were
further filtered through a 0.45 µm pore size cellulose nitrate
membrane.
2.2. Preparation of Standard Solutions
One milligram of each of the anabolic compounds was
dissolved in 1 mL of methanol to prepare an aqueous stock
solution of 1000 mg L–1 which was diluted to prepare standard
solutions of various concentrations ranging from 0.01 ng L–1 to
1 mg L–1.
2.3. Sample Treatment with Supported Liquid Membrane
(SLM)
The SLM set up (built at the Department of Analytical
Chemistry, Lund University, Lund, Sweden) shown in Fig. 1
was used for all experimental work. The liquid membrane was
prepared by dissolving 5% tri-n-octylphosphine oxide (TOPO)
in 1:1 di-n-hexyl ether/n-undecane. The liquid membrane sup-
port was a porous PTFE membrane, type FG Millipore (Bedford,
Ireland) with an average pore size of 0.2 µm, a total thickness of
175 µm of which 115 mm is polyethylene backing and a porosity
of 70%. After placement of the impregnated liquid membrane in
the separator, both channels were flushed with ultra high purity
(UHP) water to remove excess organic solvent from the surface
of the membrane. Two peristaltic pumps (Minipuls 3, Gilson,
Villiers-Le-Bel, France) were used to control the flow rates of the
donor and acceptor phases independently. The tubes used for
pumping solutions were acid-resistant (acid-flexible) (Elkay
Products, Shrewsbury, MA, USA) with an internal diameter of
1.2 mm for the donor and 0.60 mm for the acceptor. The various
parts of the flow system were connected with 0.5 mm internal
diameter PTFE tubing and Alex screw fittings. Sample and
buffer solutions in the donor stream were combined via a PTFE
T-connection and then mixed in a coil (1.0 m × 0.5 mm i.d. coiled
tubing) before entering the donor channel of the membrane
device. The buffer for the donor stream was a mixture of disodium
hydrogen phosphate and sodium dihydrogen phosphate
adjusted to pH 6.0, while the acceptor (stripping) solution was
0.4 M sulphuric acid.
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Table 1 Structures, molecular weights and CAS numbers for the six anabolic androgens compounds
studied.






Testosterone benzoate 392.5 2088–71–3
2.4. Preparation of Bovine Liver and Kidney Tissue Samples
Spiked with Anabolic Androgens
Finely sliced liver (after removal of the gall bladder) and
kidney carcasses (~20 mg) from the local abattoir were minced
and spiked with known concentrations of mixtures of anabolic
androgenic compounds. The concentration of the mixtures
ranged from 1 ng L–1 to 1 mg L–1. The spiked samples were
homogenized using a blender. The anabolic androgenic com-
pounds were then solvolysed in 1 mL ethyl acetate containing
2 µL of 0.5 M sulphuric acid at room temperature in a shaking in-
cubator for 2 h. The organic phase containing the androgenic
compounds was washed with UHP water and evaporated. The
residues were dissolved in 1 mg of methanol-water (40:60, v/v)
and then stored at 4°C until needed.
2.5. Preparation of Milk and Urine Samples Spiked with An-
abolic Androgens
Aliquots of 10.0 mL of milk or urine were transferred into
25 mL centrifuge tubes and then spiked with similar concentra-
tions of anabolic compounds as the liver and kidney tissues. The
mixtures were then solvolysed in a similar manner as described
for liver and kidney tissues.
2.6. HPLC of Anabolic Compounds
Samples were separated using a Hewlett Packard Series 1100
HPLC consisting of a binary pump system, a photodiode array
detector (DAD), a thermostated column compartment and a
vacuum degasser coupled to a Thermo electron Finnigan
LCQDECA ion trap mass spectrometer. A gradient elution mode
was used for separation with the following mobile phase
composition: A = 100% methanol; B = 85% 25 mM acetic acid in
water + 15% methanol (see Table 2). 20 µL of sample were
injected into a Waters XTerra microbore C8 (150 mm × 2.1 mm ×
3.5 µm) column. The separation was performed at a flow rate of
100 µL min–1 and monitored by ESI-MS.
2.7. The ESI-MS of Anabolic Compounds
The samples were introduced into the electrospray ionization
source by direct infusion using a Harvard Apparatus 22 syringe
pump (South Natick, Massachusetts, USA). 50 µL of dissolved
sample were mixed with 200 µL of buffer and the resulting
solution pumped at 3–5 µL min–1. 25 mM acetic acid (1:1 v/v) in
water/methanol was used as an ionization buffer. The spectra
were recorded on a ThermoQuest LCQ Deca quadrupole
ion trap mass spectrometer (San Jose, California, USA) and
processed using ThermoQuest Xcalibur software (San Jose,
California, USA).
3. Results and Discussion
The SLM system in this work used a dynamic (flowing) donor
and a stagnant acceptor solution. The most important parameter
in this sample pre-treatment process is the extraction efficiency
(% E), which is defined as the fraction of the analyte species
extracted from the donor phase via the membrane phase to the
acceptor side. %E is, however, highly dependent on other
system parameters such as the partition coefficient of the analyte
between aqueous donor phase and membrane, the donor flow
rate, the pH in both the donor and acceptor channels, the
trapping capacity in the acceptor and the concentration of the
carrier (e.g. a chemical extractant such as TOPO was used in this
experiment). In order to ensure the maximum recovery of the
analyte all the above parameters were optimized.
3.1. Optimization of the SLM System
Selectivity in the SLM extraction process of anabolic andro-
genic compounds was achieved by adjusting the pH of the
donor and acceptor channels in order to optimize the diffusion
of the uncharged analyte molecules from the donor side across
the membrane to the acceptor side. The variation of donor pH
with percentage extraction efficiency was therefore investigated
for all six anabolic androgenic compounds. Variation of % E
with pH showed that the extraction efficiency increased with an
increase in pH and reached a maximum between pH 4 and 6
(Fig. 2).
At pH values above and below the optimal values, the com-
pounds are charged and the recovery is therefore diminished
(Fig. 2) while in the intermediate pH range the compounds are
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Figure 1 (a) Set-up of the flow system used for the liquid membrane; (b) membrane separator.
Table 2 Gradient elution for anabolic androgenic compounds
Time (min) Flow rate µL min–1 A (%) B (%)
0 100 50 50
10 100 30 70
20 100 65 35
30 100 100 0
45 100 100 0
A = 100% methanol; B = 85% 25 mM acetic acid in water + 15% methanol.
neutral, resulting in better recoveries. Four of the six compounds
investigated, testosterone, 17-trenbolone, 17-trenbolone and
19-nortestosterone were efficiently recovered at an optimal
donor pH value of about 6.0. The other two, 4-androstene-3,
17-dione and testosterone benzoate, had their optimal extrac-
tion efficiencies at pH 4 and 7, respectively. The mixture was
pumped to the SLM unit at a pH of 6.0 and therefore did not
favour the efficient recovery of 4-androstene-3,17-dione and
testosterone benzoate as compared to the other four com-
pounds. This may explain the relative lower recoveries for
testosterone benzoate and 4-androstene-3,17-dione compared
to the rest of the compounds in the mixture. The reason for the
peculiar behaviour of these two compounds in a mixture may be
the replacement of the OH group at C17 with an aldehyde or an
ester group. This OH group might be utilized in hydrogen
bonding to the added chemical extractant (TOPO) hereby
trapping the compounds. TOPO as component of the liquid
membrane was found to improve the mass transfer of analytes
through the liquid membrane.47 TOPO is a known chemical
extractant (carrier) which, when incorporated into the liquid
membrane, facilitates the diffusion of analyte molecules
through the membrane due to a reversible reaction between the
analyte and the extractant molecule.53 The two lone pairs on the
oxygen atom of TOPO allow the formation of hydrogen-bonded
adducts of various composition.54 TOPO is also known to have a
high solubility in organic solvents, such as the ones used as
liquid membranes and at the same time is insoluble in water, a
property which increases its selectivity.55
3.2. SLM Enrichment of Anabolic Androgens Spiked in
Biological Matrices
Anabolic androgenic compounds were extracted using 5%
TOPO in di-n-hexylether/n-undecane as liquid membrane.
Figure 3 shows the result of extractions of 1 µg L–1 samples of the
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Figure 2 Effect of donor channel pH on the extraction efficiency of androgenic anabolic compounds spiked in urine. Liquid membrane composition:
5% TOPO in n-undecane/di-n-hexylether (1:1) donor channel flow rate = acceptor channel flow rate = 0.1 ml min–1, acceptor = 0.4 M, analyte
concentration = 0.1 µg L–1.
Figure 3 SLM/LC-ES-MS of 1 µg L–1 anabolic androgenic compounds extracted from milk, urine, kidney, liver tissue and UHP water samples.
mixtures of six anabolic andro-
gens in a variety of biological
matrices, i.e. urine, milk, kidney
and liver tissues and UHP water.
The extraction efficiency in-
creased with decreasing concen-
tration of the compounds in milk.
The observed lower extraction
efficiency at higher concentra-
tions was probably due to the sat-
uration of the trapping solution in
the acceptor side of the mem-
brane. The extraction efficiency
for 1 ng L–1 mixtures of the six
compounds in milk was found to
be 68, 74, 86, 89 and 61% for
17-trenbolone, testosterone,
19-nortestosterone, 17-trenbo-
lone, and testosterone benzoate,
respectively. 4-Androstene-3,17-




The initial part of the study was
to establish whether the investi-
gated compounds were ionizable
under atmospheric pressure ionization (API) conditions and
therefore ESI-MS active. Table 3 gives a summary of the frag-
mentation of the six compounds under ESI-MS and ESI-MS/MS
conditions; the percentage relative abundance (% RA) and the
percentage collision induced dissociation (% CID) energy used
to generate the fragment is given in brackets. For all anabolic
androgenic compounds the protonated parent ion [M + H]+ was
observed under electrospray ionization conditions. In the case of
17-trenbolone both protonated and sodiated (sodium adduct)
ions ([M + H]+ and [M + Na]+) were observed. Under ESI-MS/
MS conditions 19 nortestosterone showed three distinct peaks at
m/z 239, 257 and 275, which corresponded to [(M + H)–2H2O]
+,
[(M + H)–H2O]
+ and [M + H]+, respectively, and were observed
by varying the percentage fragmentation energy from 20 to 35%.
Testosterone was found not to ionize as well as the rest of the
compounds in the mixture. It ionized better under APCI (atmo-
spheric pressure chemical ionization) conditions. Since the
majority of the compounds in this study were, however, moni-
tored under ESI conditions we decided to monitor testosterone
under the same conditions. The objective of the ESI-MS studies
was to generate a mass spectral database for the individual
compounds, which could be used for selected ion monitoring
(SIM).
3.4. LC-MS separation and detection of anabolic androgens
All six anabolic compounds were separated on a Waters XTerra
C8 reversed-phase microbore column and detected with the
electrospray ionization-quadrupole ion trap mass spectrometer
(Fig. 4). The addition of acetic acid as a mobile phase additive not
only improved the separation but was also useful to enhance
ionization. Differences in polarity between these compounds
were exploited in their separation on a gradient HPLC system.
Several experiments were carried in which the solvent compo-
sition was varied to determine the optimum separation method.
Most solvent mixtures were unsuitable with respect to resolution
and separation time. A gradient elution based on two solvent
systems, A and B, where A = 100% methanol and B = 15%
methanol + 85% 25 mM acetic acid (Table 2) was eventually
found to give the best separation for the mixture of six anabolic
androgenic compounds (Fig. 4).
3.5. Detection Limits (DLs)
The DLs were calculated as the analyte concentration giving a
signal equal to the blank signal (yB) plus three standard
deviations (for n = 5) of the blank (sB), that is, yB + 3sB. Most of
the anabolic compounds studied in this work are controlled
substances for which no MRL values exist. This means that they
are banned by the EU and therefore a new analytical method
should be sensitive enough to monitor the presence of very low
concentrations in a variety of matrices. The detection limits
obtained in this work were comparable or better than those
reported for other methods (Table 4).
3.6. Precision and Accuracy
Bovine urine was spiked with anabolic androgens to give
samples with concentrations ranging from 1 ng L–1 to 1 mg L–1.
Five replicates were prepared and enriched using SLM and
detected with LC-ESI-MS. Table 5 shows the results of 19-nor-
testosterone spiked in urine. Precision was determined as the
percentage relative standard deviation (% RSD) which for this
compound (19-nortestosterone) ranged from 0.96 to 4.64. The
other compounds gave also acceptable values of % RSD. Accu-
racy was determined as the percentage ratio of the amount
recovered to the amount spiked and was found to range from
92–97%.
3.7. Linearity
The linearity of the SLM extraction method was investigated
experimentally by injecting standard solutions of different
concentrations ranging from 0.1 ng L–1 to 1 mg L–1 into water or
another matrix and then recovering the standard using SLM and
LC-MS. The obtained correlation coefficients (which were in the
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Table 3 ESI-MS/MS characteristic peaks of androgenic anabolic compounds under electrospray ionization
(% relative abundance,% CID =% collision induced dissociation energy).
Anabolic compound Molecular mass Ion formed (mass) Fragmentation pattern
Testosterone 288.4 289 [M + H]+ (100,% CID = 0)
311 [M + Na]+ (<5,% CID = 0)
271 [(M + H)–H2O]
+ (100,% CID = 25)
253 [(M + H)–2H2O]
+ (65,% CID = 25)
Testosterone benzoate 392.5 393.5 [M + H]+ (100,% CID = 0)
416 [M + Na]+ (<5,% CID = 0)
159 [[(M + H)–(C6H5CO + H2O + CH3)]
+
271 [[(M + H)–(C6H5CO + H2O)]
+
289 [[(M + H)–C6H5CO]
+
17-Trenbolone 270.4 271 [M + H]+
293 [M + Na]+
253 [(M + H) H2O]
+ (~5,% CID = 0)
17-Trenbolone 270.4 271 [M + H]+ (55,% CID = 0)
293 [M + Na]+ (100,% CID = 0)
253 [(M + H)–2H2O]
+
19-Nortestosterone 274.4 275.4 [M + H]+ (100,% CID = 0)
257.4 [(M + H)–H2O]
+ (80,% CID = 30)
239.4 [(M + H)–2H2O]
+ (100,% CID = 30)
4-Androstene-3,17-dione 286.4 287.4 [M + H]+ (100,% CID = 20)
269.4 [(M + H)–H2O]
+ (23,% CID = 20)
251.4 [(M + H)–2H2O]
+ (10,% CID = 20)
309.8 [M + Na]+
order of 0.99) and y-intercepts of the linear regression curve in a
response versus concentration plot showed acceptable linearity.
4. Conclusions
This work has demonstrated the potential of combining SLM
and LC-MS as a monitoring technique for veterinary anabolic
androgenic compounds. A mixture of anabolic androgenic
compounds was successfully separated using a Waters XTerra C8
microbore column and gradient elution. The presence of buffers
was crucial in achieving a good resolution and a reduction in
analysis time. The addition of 25 mM acetic acid was found to be
the most effective in achieving good separations of anabolic
androgenic compounds.
The presented method (SLM-LC-ESI-MS) offers the possibility
of monitoring the anabolic androgenic compounds directly
without derivatization as necessary in the case of GC-MS. The
application of the new method was demonstrated by analysing
anabolic androgenic compounds in various biological matrices
including urine, milk, kidney and liver tissue.
The ESI-MS spectra provided valuable information for
selected ion monitoring (SIM). It was observed that most of
the anabolic compounds in this study, had a high affinity for
hydrogen and sodium, thereby forming quasimolecular ions of
the corresponding species, i.e. [M + H]+ and [M + Na]+, respec-
tively. Other compound characteristic fragments were also iden-
tified.
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Figure 4 SIM-LC-ESI-MS chromatogram of anabolic androgens compounds mixture of 0.1 mg L–1 concentrations extracted from urine.
Table 4 Detection limits for androgenic anabolic steroid hormones.
Compound Detection limits (DLs)
Urine Liver and kidney tissues Milk
This work Literature This work Literature This work Literature
4-Androstene-3,17-dione 0.08 µg L–1 0.5 µg L–1 (60) * 0.44 µg L–1 0.02–0.1 mug kg–1 (57); 2 µg L–1 (61) 3.16 µg L–1 1 µg L–1 (61)
19-Nortestosterone 0.70 ng L–1 1.60 ng L–1 4.10 ng L–1
Testosterone 1.10 ng L–1 0.5 µg L–1 (60) 2.71 ng L–1 0.02–0.1 mug kg–1 (57); 0.1–0.4 mug 7.30 ng L–1 1 µg L–1 (61)
kg–1 (58); 2 µg L–1 (61)
17-Trenbolone 0.10 ng L–1 0.3 µg L–1 (56) 1.30 ng L–1 0.02–0.1 mug kg–1 (59); 2 µg L–1 (61) 4.15 ng L–1 1 µg L–1 (61)
17-Trenbolone 1.60 ng L–1 3.62 ng L–1 0.02–0.1 mug kg–1 (59); 2 µg L–1 (61) 9.25 ng L–1
Testosterone benzoate 0.03 µg L–1 0.22 µg L–1 5.50 µg L–1
* Values in brackets refers to references cited.
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Table 5 Method precision and accuracy study for 19-nortestosterone in bovine urine matrix.
Concentration of 19-nortestosterone Precision, measured as RSD; for n = 5 % ratio of the amount found to the
added to bovine urine matrix amount added; for n = 5.
This gives a measure for accuracy
1 mg L–1 0.96 93.6
0.1 mg L–1 1.02 93.8
0.01 mg L–1 1.12 95.1
1 µg L–1 1.28 95.7
0.1 µg L–1 1.32 96.3
0.01 µg L–1 1.94 96.8
1 ng L–1 4.64 97.2
